Careers  |  Sign In  |  Register  |   Twitter

Latest in Cardiology

Reuters Health • The Doctor's Channel Daily Newscast

Prasugrel as recommended decreases ischemic events in PCI

NEW YORK (Reuters Health) – In patients with acute coronary syndrome undergoing percutaneous coronary intervention (PCI) prasugrel shows the most favorable benefit-to-risk ratio in the core group of patients for whom this platelet inhibitor has been approved, researchers report in an August 14th...

Reuters Health • The Doctor's Channel Daily Newscast

No support for routine intra-aortic balloon counterpulsation in STEMI without shock

NEW YORK (Reuters Health) – Intra-aortic balloon counterpulsation (IABC) to augment blood flow before and for 12 hours after percutaneous coronary intervention (PCI) does not reduce infarct size or improve clinical outcomes in patients with acute anterior wall ST-segment elevation myocardial infarction...

Reuters Health • The Doctor's Channel Daily Newscast

Beta-blockers benefit chronic kidney disease patients with heart failure

NEW YORK (Reuters Health) – Beta-blockers improve all-cause mortality in patients with chronic kidney disease (CKD) and heart failure, according to a report in the September 6th Journal of the American College of Cardiology. “CKD patients with heart failure derive the same benefit from beta-blockers as...